<DOC>
	<DOC>NCT00717561</DOC>
	<brief_summary>The purpose of this study is to assess if a therapy with oral and intravenous moxifloxacin is as effective as a therapy with intravenous ceftriaxone + intravenous azithromycin followed by oral amoxicilline/clavulanate and oral clarithromycin in the treatment of community-acquired pneumonia.</brief_summary>
	<brief_title>A Study to Assess the Efficacy and Safety of IV/PO Moxifloxacin in Subjects With Community-acquired Pneumonia</brief_title>
	<detailed_description />
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Ceftriaxone</mesh_term>
	<mesh_term>Clarithromycin</mesh_term>
	<mesh_term>Clavulanic Acid</mesh_term>
	<mesh_term>Clavulanic Acids</mesh_term>
	<mesh_term>Amoxicillin-Potassium Clavulanate Combination</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Norgestimate, ethinyl estradiol drug combination</mesh_term>
	<criteria>Hospitalized nonICU patients (age, &gt;= 18 years) Clinical signs and symptoms of CAP, with PSI score IV or V Radiologically confirmed evidence of a new and/or progressive infiltrate(s) Requirement for initial parenteral therapy At least 2 of the following conditions: Productive or non productive cough with or without purulent or mucosus or mucopurulent sputum Dyspnea and/or tachypnea (respiratory rate of &gt; 20 breaths/min) Rigors and/or chills Pleuritic chest pain Auscultatory findings of rales and/or crackles on pulmonary examination and/or evidence of pulmonary consolidation Fever (an oral temperature of &gt;= 38 째C, a rectal temperature of &gt;= 39 째C, or a tympanic temperature of &gt;= 38.5 째C) or hypothermia (rectal or core temperature of &lt; 35 째C), and a WBC count of &gt;= 10,000 cells/mm3 or &gt;= 15% immature neutrophils bands; regardless of peripheral WBC count) or leukopenia (total WBC count of &lt; 4500 cells/mm3) Written informed consent PSI Class IIII and V with need for ICU admission Hospitalization for &gt; 48 hours before developing pneumonia, or discharge from hospital &lt; 30 days prior. Note: patients currently residing in residential longterm facilities can be enrolled in the study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>CAP</keyword>
	<keyword>Community-acquired pneumonia</keyword>
</DOC>